Post-Traumatic Stress Disorder (PTSD) and Seroquel
Completed · Not applicable
Conditions studied: Post-Traumatic Stress Disorder
In brief
This 8 weeks study will investigate therapeutic responses to Seroquel pharmacotherapy in PTSD.
Key facts
- Study ID
- NCT01066156
- Run by
- Cambridge Health Alliance
- People needed
- 34
- Starts
- 2010-02-01
- Expected to finish
- 2015-03-01
- Last updated by the study team
- 2017-05-30
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Provision of written informed consent
- Fluency in English
- A diagnosis of PTSD
- No pregnancy
- Right-handedness
You may not qualify if…
- Pregnancy or lactation
- Any cognitive impairment that precludes informed consent
- Known intolerance or lack of response to Seroquel
- Previous enrollment or randomization of treatment in the present study
- Participation in another drug trial within 4 weeks prior enrollment into this study
- Patients with Diabetes Mellitus
- History of allergic reaction or hypersensitivity to Seroquel
- Contraindications to magnetic resonance imaging
- Treatment with an effective medication for PTSD
Where it is running
- Central Street Health Center — Somerville, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.